about
3.4 kb mitochondrial genome deletion serves as a surrogate predictive biomarker for prostate cancer in histopathologically benign biopsy coresCytoplasmic hybrid (cybrid) cell lines as a practical model for mitochondriopathiesChip-based mtDNA mutation screening enables fast and reliable genetic diagnosis of OXPHOS patients.Mitochondrial DNA mutations in pancreatic cancerThe pseudo-mitochondrial genome influences mistakes in heteroplasmy interpretationMitochondria in cybrids containing mtDNA from persons with mitochondriopathies.External contamination in single cell mtDNA analysis.Multiple strand displacement amplification of mitochondrial DNA from clinical samples.Facile whole mitochondrial genome resequencing from nipple aspirate fluid using MitoChip v2.0.Performance of mitochondrial DNA mutations detecting early stage cancer.Mitochondrial variants in schizophrenia, bipolar disorder, and major depressive disorderBiomarker Validation for Aging: Lessons from mtDNA Heteroplasmy Analyses in Early Cancer Detection.Do alterations in mitochondrial DNA play a role in breast carcinogenesis?Downregulation of carnitine acyl-carnitine translocase by miRNAs 132 and 212 amplifies glucose-stimulated insulin secretionMitochondrial DNA mutations in head and neck cancer are infrequent and lack prognostic utility.Mitochondrial DNA mutations in preneoplastic lesions of the gastrointestinal tract: a biomarker for the early detection of cancer.High copy number of mitochondrial DNA (mtDNA) predicts good prognosis in glioma patients.Somatic mitochondrial DNA mutations in prostate cancer and normal appearing adjacent glands in comparison to age-matched prostate samples without malignant histology.An oligonucleotide microarray for high-throughput sequencing of the mitochondrial genomeReal-time telomerase activity measurements for detection of cancer.Molecular biomarkers for cancer detection in blood and bodily fluids.Does mitochondrial DNA play a role in Parkinson's disease? A review of cybrid and other supportive evidence.HMGA1 levels influence mitochondrial function and mitochondrial DNA repair efficiencyTumor markers: A diagnostic toolA matter of life, death and diseases: mitochondria from a proteomic perspective.The mitochondrial genome: a biosensor for early cancer detection?Noninvasive approaches for detecting and monitoring bladder cancer.Prevalence of somatic mitochondrial mutations and spatial distribution of mitochondria in non-small cell lung cancer.Exhaled breath condensate as a source of biomarkers for lung carcinomas. A focus on genetic and epigenetic markers-A mini-review.Mitochondria in chronic obstructive pulmonary disease and lung cancer: where are we now?High-performance detection of somatic D-loop mutation in urothelial cell carcinoma patients by polymorphism ratio sequencing.D-loop somatic mutations and ∼5 kb "common" deletion in mitochondrial DNA: important molecular markers to distinguish oral precancer and cancer.
P2860
Q24594248-0E43CAD9-C8D6-4704-A96C-5642C45B45F4Q26859496-43B017EE-76AC-4160-B1B0-BFFE6921CF08Q27990522-17AB95BF-057B-41DC-8FFF-025DB50DF9D9Q28247396-F37A6616-1C13-4371-A4C3-11A794546DA4Q28768152-A783F7F4-0692-46FF-BF55-F11E24F30E5FQ30442688-D1042804-4A5E-484B-B798-D07F957FA230Q33292683-BB8C341E-CF5C-45B9-A828-4A6D0E716375Q33318717-6222D68E-3FB1-4038-8AF9-A46BEA098B9BQ33327587-995C296B-5A04-4575-9BAF-E83799433CDBQ33373844-3362D114-7881-4EA4-AF59-A8D72817A4DDQ33418617-842220FE-795A-4152-90D9-F8F29C558EFEQ33520448-47AB7B72-7619-44A5-948E-0AF25FE82C98Q33985107-295091BB-FB37-40B3-86CF-E96ADD1A6B55Q34393337-59DE7B20-6FA6-46E4-BC0A-9D0EA94CBCE4Q34806878-278B90D7-0E24-4F0C-AA1C-7ADCE85319D4Q35574219-DF637133-88F3-47F0-A4B9-80DE0E3E86C7Q35666483-4FEE35F9-F6FF-4D6A-B3F8-B2F32EEB11F2Q35790237-1C1A27DF-9CAA-4F81-BA23-7B651608D4A8Q35790280-31B60D1A-051F-4731-BB7E-D48B5825F4E8Q36252196-CE3D1D73-F643-4DFC-BEF0-6BA4B8CB1692Q36627755-C8B60CA5-70CB-4023-A0DB-AAC227C47EC8Q36813613-A25CFF59-AE63-4685-A17D-507F4912A436Q37374734-1181E712-70D1-4F2C-8BF5-F2CF66EB178DQ37591660-5E6D9231-C571-4F7E-BFA0-EE5274048A57Q38081957-DAFB2F78-9763-482A-AE9B-2F37516FA210Q38089243-75F9A611-3151-4142-A259-8B2837F6FA99Q38286089-632E43D1-715B-407A-8393-AE9B246B395DQ38756331-7032CBC1-CB98-47C5-BBDA-C45E43E033F2Q38915216-E169BBC5-9D2D-4C4F-BD32-6DA7A7D9DE2DQ39361908-FE7CE2DC-46DF-466D-879C-A3B231F4EBAAQ46633781-E8B053BB-DB31-4FAB-8C06-B06FD4EE896DQ46796420-F76AFBC1-0022-4DF4-B1B0-EDC2EF6953B6
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Mitochondrial DNA as a cancer biomarker
@ast
Mitochondrial DNA as a cancer biomarker
@en
type
label
Mitochondrial DNA as a cancer biomarker
@ast
Mitochondrial DNA as a cancer biomarker
@en
prefLabel
Mitochondrial DNA as a cancer biomarker
@ast
Mitochondrial DNA as a cancer biomarker
@en
P2093
P2860
P1476
Mitochondrial DNA as a cancer biomarker
@en
P2093
Anirban Maitra
Catherine D O'Connell
David Sidransky
Delphine Ally
John P Jakupciak
Maura E Markowitz
Michael Coble
Peter E Barker
Sudhir Srivastava
Wendy Wang
P2860
P304
P356
10.1016/S1525-1578(10)60553-3
P577
2005-05-01T00:00:00Z